Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Gartner releases 2018 Magic Quadrant for Integrated Risk Management August 9, 2018 Does Automotive Wheel Machining Benefit From a Purpose-Built Wheel Machine? October 27, 2017 How Additive Manufacturing Drives Sustainable Manufacturing August 21, 2019